Positive Results at End of Phase 3 Trial of Candidate Tuberous Sclerosis Complex Drug – CBD
According to a press release from the British biotechnology company GW Pharmaceuticals, the company has reported successful results at the conclusion of its phase 3 trial of tuberous sclerosis complex…